Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)

NCT03833336 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Normal Ejection Fraction
Ferropenic Anemia

Interventions

OTHER: Placebo
DRUG: Ferric carboxymaltose
DRUG: Ferroglycine Sulfate
DRUG: Sucrosomial Iron

Sponsor

Institut de Recerca Biomèdica de Lleida

Collaborators

[object Object]